Ipsum - About the company
Ipsum is a seed company based in Medellin (Colombia), founded in 2014 by Mike Hoey. It operates as a CRO helping life sciences companies by setting-up and managing clinical trials. Ipsum has raised $200K in funding. The company has 47 active competitors, including 4 funded and 3 that have exited. Its top competitors include companies like United BioSource Corporation, Hikinger Pharmaceutical Technology and River Vision Development.
Company Details
Ipsum Clinical is a full-service CRO offering Phase II - IV clinical trial services. The company has expertise in the tropical diseases of Malaria, Leishmaniasis, Dengue and Chagas and offers research services of project planning, feasibility study, monitoring, registration of products, and management of drugs. Some of its services include main services are: feasibility studies, project planning, clinical plan development, site identification and assessment, regulatory affairs, coordination of investigational sites, clinical monitoring, Medical Monitoring, Quality Assurance, Management of drug and laboratory samples, Registration of new products/indications.
- Website
- ipsumcro.com
- Social
- Email ID
- *****@ipsumcro.com
Key Metrics
Founded Year
2014
Location
Medellin, Colombia
Stage
Seed
Total Funding
$200K in 1 round
Latest Funding Round
Investors
Ranked
7th among 47 active competitors
Employee Count
8 as on May 31, 2026
Similar Companies
Sign up to download Ipsum's company profile
Ipsum's funding and investors
Ipsum has raised a total funding of $200K over 1 round. Its latest funding round was a Seed round on Jul 02, 2015 for $*****. 1 investor participated in its latest round. Ipsum has 1 institutional investor.
Here is the list of recent funding rounds of Ipsum:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Jul 02, 2015 | 4024786 | Seed | 9399114 | 3735583 | 9281817 | 6257912 |
Access funding benchmarks and valuations. Sign up today!View details of Ipsum's funding rounds and investors
Ipsum's founders and board of directors
Founder? Claim ProfileThe founders of Ipsum is Mike Hoey.
Here are the details of Ipsum's key team members:
- Mike Hoey: Founder & CEO of Ipsum.
View details of Ipsum's Founder profiles and Board Members
Ipsum's employee count trend
Ipsum has 8 employees as of May 26. Here is Ipsum's employee count trend over the years:
Uncover Ipsum's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Ipsum's Competitors and alternates
Top competitors of Ipsum include United BioSource Corporation, Hikinger Pharmaceutical Technology and River Vision Development. Here is the list of Top 10 competitors of Ipsum, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | United BioSource Corporation 2003, Blue Bell (United States), Acquired | Uniting evidence and access to improve patient outcomes for biopharma | $278M | 60/100 | |
2nd |  Hikinger Pharmaceutical Technology 2006, Beijing (China), Series B | Provider of phase I-IV drug research and development services | - | 28/100 | |
3rd |  River Vision Development 2011, Series A | Provider of late stage clinical development services | $17M | 28/100 | |
4th | O4 Research 2009, Belfast (United Kingdom), Unfunded | Manufacturer of conductive metal-clad fibers for diverse applications | - | - | 27/100 |
5th | Concentrics Research 1999, Indianapolis (United States), Acquired | Late-stage (Phase II-IV trials) CRO | - | - | 26/100 |
6th | Indian CRO offering comprehensive clinical research and site-management services for for phase II - IV clinical studies | - | - | 26/100 | |
7th | CRO helping life sciences companies by setting-up and managing clinical trials | $200K | 26/100 | ||
8th |  US Biotest 2000, San Luis Obispo (United States), Funding Raised | Provider of late-stage clinical trials studies for multiple therapeutic diseases | - | 24/100 | |
9th | Provider of online airport parking space booking and management services | - | - | 24/100 | |
10th | Nexus Biosciences 2012, Carlsbad (United States), Funding Raised | CRO specializing in late stage, observational and post-approval studies | - | 23/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Ipsum's competitors? Click here to see the top ones
Ipsum's Investments and acquisitions
Ipsum has made no investments or acquisitions yet.
Are you a Founder ?
FAQs about Ipsum
Explore our recently published companies
- Uvtcpl - India based, Unfunded company
- Diamondexch99 - Unfunded company
- Krishna's Herbal & Ayurveda - Jodhpur based, 2007 founded, Funding Raised company
- Dash - Atlanta based, 2025 founded, Unfunded company
- Bregma Science LLP - Bengaluru based, Unfunded company
- Nordible - Mumbai based, 2015 founded, Unfunded company
